Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mirati Therapeutics Inc.

    NASDAQ: MRTX · Real-Time Price · USD
    58.70
    -0.10 (-0.17%)
    At close: Jan 22, 2024, 9:00 PM

    Mirati Therapeutics Statistics

    Share Statistics

    Mirati Therapeutics has 70.15M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 70.15M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 100

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -3.44 and the forward PE ratio is null. Mirati Therapeutics's PEG ratio is -0.2.

    PE Ratio

    n/a
    		 -3.44

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 204.88

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.56

    P/FCF Ratio

    n/a
    		 -4.43

    PEG Ratio

    n/a
    		 -0.2
    Financial Ratio History

    Enterprise Valuation

    Mirati Therapeutics has an Enterprise Value (EV) of 2.36B.

    EV / Sales

    n/a
    		 190.1

    EV / EBITDA

    n/a
    		 -3.12

    EV / EBIT

    n/a
    		 -4.14

    EV / FCF

    n/a
    		 -4.11

    Financial Position

    The company has a current ratio of 6.96, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 6.96

    Quick Ratio

    n/a
    		 6.94

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 42.3

    Financial Efficiency

    Return on Equity is -74.35% and Return on Invested Capital is -75.68%.

    Return on Equity

    n/a
    		 -74.35%

    Return on Assets

    n/a
    		 -61.6%

    Return on Invested Capital

    n/a
    		 -75.68%

    Revenue Per Employee

    n/a
    		 $21,185.69

    Profits Per Employee

    n/a
    		 $-1,262,124.36

    Employee Count

    n/a
    		 587

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 0.2

    Taxes

    Income Tax

    n/a
    		 508K

    Effective Tax Rate

    n/a
    		 -0.07%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.77, so Mirati Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.77

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 57.75

    200-Day Moving Average

    n/a
    		 45.58

    Relative Strength Index (RSI)

    n/a
    		 56.14

    Average Volume (20 Days)

    n/a
    		 1,778,618

    Income Statement

    In the last 12 months, Mirati Therapeutics had revenue of 12.44M and earned -740.87M in profits. Earnings per share was -13.18.

    Revenue

    n/a
    		 12.44M

    Gross Profit

    n/a
    		 11.84M

    Operating Income

    n/a
    		 -759.59M

    Net Income

    n/a
    		 -740.87M

    EBITDA

    n/a
    		 -756.66M

    EBIT

    n/a
    		 -758.32M

    Earnings Per Share (EPS)

    n/a
    		 -13.18
    Full Income Statement

    Balance Sheet

    The company has 235.26M in cash and 51.51M in debt, giving a net cash position of 183.75M.

    Cash & Cash Equivalents

    n/a
    		 235.26M

    Total Debt

    n/a
    		 51.51M

    Net Cash

    n/a
    		 183.75M

    Retained Earnings

    n/a
    		 -2.45B

    Total Assets

    n/a
    		 1.13B

    Working Capital

    n/a
    		 898.7M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -570.57M and capital expenditures -4.85M, giving a free cash flow of -575.42M.

    Operating Cash Flow

    n/a
    		 -570.57M

    Capital Expenditures

    n/a
    		 -4.85M

    Free Cash Flow

    n/a
    		 -575.42M

    FCF Per Share

    n/a
    		 -10.23
    Full Cash Flow Statement

    Margins

    Gross margin is 95.18%, with operating and profit margins of -6107.98% and -5957.44%.

    Gross Margin

    n/a
    		 95.18%

    Operating Margin

    n/a
    		 -6107.98%

    Pretax Margin

    n/a
    		 -5953.35%

    Profit Margin

    n/a
    		 -5957.44%

    EBITDA Margin

    n/a
    		 -6084.43%

    EBIT Margin

    n/a
    		 -6107.98%

    FCF Margin

    n/a
    		 -4627.06%

    Dividends & Yields

    MRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -29.08%

    FCF Yield

    n/a
    		 -22.58%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MRTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 3, 2013. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Jul 3, 2013

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 8.55

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist